Could ultrasound replace radioactive dye for cancer staging?

NCT ID NCT07310758

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a special ultrasound using a contrast agent (Sonazoid) can find sentinel lymph nodes as accurately as the standard radioactive tracer method in people with melanoma, breast cancer, or head & neck cancer. About 91 adults will take part, and the goal is to see if the ultrasound method is sensitive enough to replace the radioactive approach. If successful, it could offer a safer, needle-free option for cancer staging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Netherlands Cancer Institute

    RECRUITING

    Amsterdam, North Holland, 1066 CX, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.